共 74 条
- [1] Blandin L., Douge A., Fayard A., Bay J.O., Berlie G., Pereira B., Et al., Platelet transfusion refractoriness and anti-HLA immunization, Transfusion, 61, (2021)
- [2] Hod E., Schwartz J., Platelet transfusion refractoriness, Br J Haematol, 142, (2008)
- [3] Prodger C.F., Rampotas A., Estcourt L.J., Stanworth S.J., Murphy M.F., Platelet transfusion: Alloimmunization and refractoriness, Semin Hematol, 57, (2020)
- [4] Doughty H.A., Murphy M.F., Metcalfe P., Rohatiner A.Z., Lister T.A., Waters A.H., Relative importance of immune and non-immune causes of platelet refrac-toriness, Vox Sang, 66, (1994)
- [5] Dutcher J.P., Schiffer C.A., Aisner J., Wiernik P.H., Long-term follow-up patients with leukemia receiving platelet transfusions: identification of a large group of patients who do not become alloimmunized, Blood, 58, (1981)
- [6] Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions, N Engl J Med, 337, (1997)
- [7] Youssef L.A., Spitalnik S.L., Transfusion-related immunomodulation: a reappraisal, Curr Opin Hematol, 24, (2017)
- [8] Remy K.E., Hall M.W., Cholette J., Juffermans N.P., Nicol K., Doctor A., Et al., Mechanisms of red blood cell transfusion-related immunomodulation, Transfusion, 58, (2018)
- [9] Goubran H., Sheridan D., Radosevic J., Burnouf T., Seghatchian J., Transfusion-related immunomodulation and cancer, Transfus Apher Sci, 56, (2017)
- [10] Gilson C.R., Zimring J.C., Alloimmunization to transfused platelets requires priming of CD4+ T cells in the splenic microenvironment in a murine model, Transfusion, 52, (2012)